Cargando…

Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy

SIMPLE SUMMARY: Several therapeutic options exist for patients with advanced BRAF-mutant melanoma. Biomarkers able to identify patients with refractory disease or with poor progression-free survival (PFS) and overall survival (OS) expectancy with respect to specific treatments might allow a more per...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levati, Lauretta, Bassi, Cristian, Mastroeni, Simona, Lupini, Laura, Antonini Cappellini, Gian Carlo, Bonmassar, Laura, Alvino, Ester, Caporali, Simona, Lacal, Pedro Miguel, Narducci, Maria Grazia, Molineris, Ivan, De Galitiis, Federica, Negrini, Massimo, Russo, Giandomenico, D’Atri, Stefania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367338/ https://www.ncbi.nlm.nih.gov/pubmed/35954369 http://dx.doi.org/10.3390/cancers14153706

Ejemplares similares

miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
por: Caporali, Simona, et al.
Publicado: (2019)

Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib
por: Caporali, Simona, et al.
Publicado: (2017)

Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by inhibition of NF-κB or the PI3K/mTOR signalling pathway
por: Caporali, Simona, et al.
Publicado: (2015)

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2018)

Expression and Diagnostic Value of miR-497 and miR-1246 in Hepatocellular Carcinoma
por: Chen, Shuying, et al.
Publicado: (2021)

Neuropilin-1 expressing melanoma cells as a model to study the aggressiveness of metastatic melanoma
por: Ruffini, Federica, et al.
Publicado: (2015)

Serum miR-1290 and miR-1246 as Potential Diagnostic Biomarkers of Human Pancreatic Cancer
por: Wei, Jia, et al.
Publicado: (2020)

Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1
por: Ruffini, Federica, et al.
Publicado: (2017)

Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer
por: Xu, Yi-Fan, et al.
Publicado: (2017)

Usefulness of serum miR-1246/miR-106b ratio in patients with esophageal squamous cell carcinoma
por: Hoshino, Isamu, et al.
Publicado: (2020)

A Review on the Role of miR-1246 in the Pathoetiology of Different Cancers
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1α expression
por: Lou, C, et al.
Publicado: (2016)

Circulating MiR-210 and MiR-1246 as Potential Biomarkers for Differentiating Hepatocellular Carcinoma from Metastatic Tumors in the Liver
por: Ahmed, Emad K., et al.
Publicado: (2019)

Detection of miR-1246, miR-23a and miR-451 in sera of colorectal carcinoma patients: a case-control study in Cairo University hospital
por: Salah, Mona, et al.
Publicado: (2020)

Differential expression of miR-1297, miR-3191-5p, miR-4435, and miR-4465 in malignant and benign breast tumors
por: Mosapour, Abbas, et al.
Publicado: (2020)

Circulating miR-206 and miR-1246 as Markers in the Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
por: Córdoba-Lanús, Elizabeth, et al.
Publicado: (2023)

NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug
por: Caporali, Simona, et al.
Publicado: (2012)

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
por: Nemecz, Miruna, et al.
Publicado: (2023)

Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer
por: Niemira, Magdalena, et al.
Publicado: (2023)

The Diagnostic Power of Circulating miR-1246 in Screening Cancer: An Updated Meta-analysis
por: Huynh, Khanh Quang, et al.
Publicado: (2023)

Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression
por: Zhang, Wen Cai, et al.
Publicado: (2016)

miR-1246 Targets CCNG2 to Enhance Cancer Stemness and Chemoresistance in Oral Carcinomas
por: Lin, Shih-Shen, et al.
Publicado: (2018)

Exosome-packaged miR-1246 contributes to bystander DNA damage by targeting LIG4
por: Mo, Li-Jun, et al.
Publicado: (2018)

The role of miR-485-5p/NUDT1 axis in gastric cancer
por: Duan, Jingjing, et al.
Publicado: (2017)

LINC00052 regulates the expression of NTRK3 by miR-128 and miR-485-3p to strengthen HCC cells invasion and migration
por: Xiong, Dongmei, et al.
Publicado: (2016)

Loss of miR-204 expression is a key event in melanoma
por: Galasso, Marco, et al.
Publicado: (2018)

5'‑isomiR is the most abundant sequence of miR‑1246, a candidate biomarker of lung cancer, in serum
por: Aiso, Toshiko, et al.
Publicado: (2023)

Reduced Circulating Levels of miR-491-5p and miR-485-3p Are Associated with the Occurrence of Vertebral Fractures in Postmenopausal Women with Osteoporosis
por: Xu, Jixi, et al.
Publicado: (2022)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015)

miR-485-5p alleviates Alzheimer’s disease progression by targeting PACS1
por: He, Chuan, et al.
Publicado: (2021)

miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF
por: Varendi, Kärt, et al.
Publicado: (2014)

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
por: Qiu, Shuwei, et al.
Publicado: (2013)

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
por: Schee, Kristina, et al.
Publicado: (2012)

MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome
por: Narducci, M G, et al.
Publicado: (2011)

Exosomes derived from stem cells of human deciduous exfoliated teeth inhibit angiogenesis in vivo and in vitro via the transfer of miR-100-5p and miR-1246
por: Liu, Panpan, et al.
Publicado: (2022)

Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
por: Cooks, Tomer, et al.
Publicado: (2018)

Circulating miR-1246 in the Progression of Chronic Obstructive Pulmonary Disease (COPD) in Patients from the BODE Cohort
por: Cazorla-Rivero, Sara, et al.
Publicado: (2020)

miR‐1246 is implicated as a possible candidate for endometrium remodelling facilitating implantation in buffalo (Bubalus bubalis)
por: Dubey, Pratiksha, et al.
Publicado: (2022)

Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer
por: Larki, Pegah, et al.
Publicado: (2018)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3ti9l9jo2ldd1tue6uumf5tgmk